Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Costs and outcomes of an intervention programme for offenders with personality disorders.

Barrett B, Byford S.

Br J Psychiatry. 2012 Apr;200(4):336-41. doi: 10.1192/bjp.bp.109.068643. Epub 2012 Feb 23. Erratum in: Br J Psychiatry. 2012 Jun;200(6):514.

2.

The cost-effectiveness of the dangerous and severe personality disorder programme.

Barrett B, Tyrer P.

Crim Behav Ment Health. 2012 Jul;22(3):202-9. doi: 10.1002/cbm.1829. Review.

PMID:
22711616
3.

Service costs for severe personality disorder at a special hospital.

Barrett B, Byford S, Seivewright H, Cooper S, Tyrer P.

Crim Behav Ment Health. 2005;15(3):184-90.

PMID:
16575796
4.

Cost implications of treatment non-completion in a forensic personality disorder service.

Sampson CJ, James M, Huband N, Geelan S, McMurran M.

Crim Behav Ment Health. 2013 Dec;23(5):321-35. doi: 10.1002/cbm.1866. Epub 2013 Jul 23.

5.

Economic evaluation of treatments for children with severe behavioural problems.

Muntz R, Hutchings J, Edwards RT, Hounsome B, O'Céilleachair A.

J Ment Health Policy Econ. 2004 Dec;7(4):177-89.

PMID:
15701933
6.

Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Annemans L, Rémy V, Oyee J, Largeron N.

Pharmacoeconomics. 2009;27(3):231-45. doi: 10.2165/00019053-200927030-00006.

PMID:
19354343
7.

The cost-effectiveness of testing for hepatitis C in former injecting drug users.

Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.

8.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

9.
10.

Strengthening the status of psychotherapy for personality disorders: an integrated perspective on effects and costs.

Bartak A, Soeteman DI, Verheul R, Busschbach JJ.

Can J Psychiatry. 2007 Dec;52(12):803-10. Review.

PMID:
18186181
11.

Pursuing cost-effectiveness in mental health service delivery for youth with complex needs.

Grimes KE, Schulz MF, Cohen SA, Mullin BO, Lehar SE, Tien S.

J Ment Health Policy Econ. 2011 Jun;14(2):73-83.

PMID:
21881163
12.

Dangerous and severe personality disorder and in need of treatment.

Mullen PE.

Br J Psychiatry Suppl. 2007 May;49:s3-7.

PMID:
17470940
13.

The dangerous and severe personality disorder experiment--review of empirical research.

Völlm B, Konappa N.

Crim Behav Ment Health. 2012 Jul;22(3):165-80. doi: 10.1002/cbm.1833. Review.

PMID:
22711613
14.

Cost-effectiveness of treating first-episode psychosis: five-year follow-up results from an Italian early intervention programme.

Cocchi A, Mapelli V, Meneghelli A, Preti A.

Early Interv Psychiatry. 2011 Aug;5(3):203-11. doi: 10.1111/j.1751-7893.2011.00261.x. Epub 2011 Jul 6. Erratum in: Early Interv Psychiatry. 2011 Nov;5(4):389. Angelo, Cocchi [corrected to Cocchi, Angelo]; Vittorio, Mapelli [corrected to Mapelli, Vittorio]; Anna, Meneghelli [corrected to Meneghelli, Anna]; Antonio, Preti [corrected to Preti, Antonio].

PMID:
21729243
15.

THE OFFENDER PERSONALITY DISORDER PATHWAY: RISKING REHABILITATION?

McRae L.

Med Law Rev. 2015 Summer;23(3):321-47. doi: 10.1093/medlaw/fwv021. Epub 2015 Jun 1.

PMID:
26037377
16.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

17.

Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.

Davis A, Smith P, Ferguson M, Stephens D, Gianopoulos I.

Health Technol Assess. 2007 Oct;11(42):1-294.

18.

The economic analysis of prevention: an illustration involving children's behavior problems.

Foster EM, Jones DE.

J Ment Health Policy Econ. 2007 Dec;10(4):165-75.

PMID:
18166828
19.

Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.

Wiley-Exley E, Domino ME, Maxwell J, Levkoff SE.

J Ment Health Policy Econ. 2009 Dec;12(4):205-13.

PMID:
20195008
20.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

Items per page

Supplemental Content

Write to the Help Desk